Search Orphan Drug Designations and Approvals
-
Generic Name: | Cannabidiol |
---|---|
Date Designated: | 09/16/2020 |
Orphan Designation: | Treatment of 22q.11.2 deletion syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Zynerba Pharmaceuticals, Inc. 80 West Lancaster Avenue Suite 300 Devon, Pennsylvania 19333 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-